Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world. Roche's investment in startup Regor Therapeutics for a new breast cancer drug, worth $850 million, shows their commitment to innovative research. Prime's focus on gene editing research and partnership with Bristol Myers signifies the evolving landscape of biopharma collaborations. Aktis raising $175 million for radiopharma drug development, with support from invest...